Testing Experimental Medication in Healthy Subjects
common.study.values.description
“A Study of Two Formulations of Ixekizumab in Healthy Participants”
The purpose of this study is to compare two different formulations of ixekizumab. One formulation (Reference) is approved by the Food and Drug Administration (FDA) and one formulation (Test) is not approved. This study will compare how much of each formulation gets into the blood stream. Information about any side effects that may occur will also be collected. The study will last up to about four months for each participant.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Ixekizumab
Administered SC.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Bioequivalence of an Alternate Ixekizumab Formulation Compared to the Commercial Formulation in Healthy Subjects
common.study.values.clinical-trial-id
NCT04259346
participant.views.study.view.id
elYJJa
